Introduction
Human mast cells contain a variety of preformed secretory granule mediators, including two enzymes designated tryptase (1, 2) and chymase (3) (4) (5) . A carboxypeptidase (CP)l activity, thought to be carboxypeptidase A (CPA) or CPA-like, has been identified in rodent mast cells (6, 7) and purified from rat Address reprint requests to Dr. Goldstein peritoneal mast cells (6) and rat skeletal muscle (8) . A CP activity was recently identified in highly purified human mast cells from lung (9) . The carboxypeptidase is 30,000-35,000 D, is active at neutral to alkaline pH, is inhibited by potato tuber carboxypeptidase inhibitor (PCI), EDTA, phenanthroline, and 8-hydroxyquinoline, and is released from mast cells by immunologic challenge. These characteristics suggest that the CP is a mast cell secretory granule zinc-metalloexopeptidase, related to the CPs purified from pancreas (10) . A CP activity identical with respect to pH optimum, molecular mass, inhibitor profile, and enzymatic activity was also identified in preparations of dispersed skin mast cells and in extracts from whole human skin (9) . In this article we report the purification and physicochemical characterization of the human mast cell CP, and demonstrate that the enzyme closely resembles carboxypeptidase B (CPB) with regard to primary structure, but functionally acts similarly although not identically to CPA.
Methods

Materials
Angiotensin I (Al), angiotensin II (All), des-Leu'0 Al, bradykinin, and des-Arg9 bradykinin (Peninsula Laboratories, Inc., San Carlos, CA); polyethylene glycol (PEG) 3350, NaClO4, 85% H3PO4, and CH3CN (HPLC grade) (Fisher Scientific Co., Medford, MA); phenylisothiocyanate (PITC), trifluoroacetic acid (TFA) (Pierce Chemical Co., Rockford, IL); N-carbobenzoxy-glycyl-L-phenylalanine (N-CBZ-Gly-Phe), N-carbobenzoxy-glycyl-L-arginine (N-CBZ-Gly-Arg), bovine pancre-
Isolation ofdispersed human skin mast cells
Foreskins from circumcisions of neonates and adults, and adult facial skin from cosmetic surgical procedures were stored in Dulbecco's modified Eagle's medium with 1.5% fetal bovine serum overnight at 40C. Dispersed mast cells were obtained by enzymatic digestion as described (9) . Percoll gradients were made by layering 3-ml fractions of 50%, 70%, and 80% in a 15-ml conical tube. Cells were suspended in media and layered over the gradient, which was centrifuged at 500 g for 15 min. Mast cells were identified by Alcian blue staining. Viability of mast cells was greater than 99% as assessed by trypan blue dye exclusion.
To centrifuged at 4°C at 10,000 g, the pellet was extracted for another hour in the same solution, and the supernatants were combined and stored at -70°C. PCI affinity chromatography. Extracts were subjected to PCI affinity chromatography using a modification ofthe procedure described by Everitt and Neurath (6) and Petra (15) . The PCI affinity column was prepared by linking 5-10 mg of PCI per 1.0 ml of CNBr-activated Sepharose 4B as described by the manufacturer. Extracts were applied at room temperature to a 1 -ml or 5-ml column previously equilibrated in the skin extraction buffer. The column was then washed with 20 bed volumes of 10 mM Tris, pH 7.4, 1 M NaCI, 10 MM SBTI, 0.1% PEG, and then with 20 bed volumes of the identical buffer without SBTI.
The column was eluted with 100 bed volumes of 0.1 M Na2CO3, pH 1 1.4, 2 M NaCl, 0.1% PEG, and collected in 5-ml fractions for the I -ml column, or in a single volume. The eluate was immediately neutralized in 1 vol of 1 M Hepes, pH 6.9, 2 M NaCl, 0.1% PEG per 9 vol ofeluate. Samples were assayed for carboxypeptidase activity in the presence and absence of PCI, and for protein by absorbance at 280 nm and by Coomassie Brilliant Blue dye binding (Bio-rad Laboratory, Richmond, CA), standardized using bovine serum albumin. The active eluate was concentrated at 4VC using a 50-ml concentrating chamber (Amicon Corp., Danvers, MA) with a PM 10 membrane.
Procedures for physicochemical characterization HPLC and spectral analysis. Affinity-purified material was analyzed by HPLC (5-ml system, Rainin Instrument Co., Inc., Woburn, MA) using a reverse-phase system with a C-8 RP 300 2.1 X 30 mm column (Brownlee Labs, Santa Clara, CA), employing a linear gradient of0.1% TFA in water to 0.1% TFA in 70% acetonitrile over 45 min at 0.2 ml/min. Protein in the eluate was monitored at 215 nm with a model 1040A Diode Array HPLC detection system (Hewlett Packard Co., Palo Alto, CA). Spectra were collected and analyzed by a model 300 series computer (Hewlett Packard Co.).
Sephacryl S200 gelfiltration. The concentrated eluate was filtered through a 1.6 X 91 cm Sephacryl S-200 column run at 4VC in 0.01 M Tris-HCI, pH 7.4, 1M NaCl, 0.1% PEG at 15 ml/h. Fractions of 2-ml vol were collected, screened for protein by OD280, and Coomassie Brilliant Blue dye binding, and assessed for activity.
PAGE. Aliquots of reduced and alkylated, and unreduced purified CP were subjected to SDS-PAGE as described (16) . Gels 2.5 Ml neat, was added and the reaction was incubated for 2 h. The sample was desalted by HPLC using a reverse-phase system using a 2.1 X 30-mm C-8, RP 300 column (Rainin Instrument Co., Inc.) The recovered derivatized protein was dried and hydrolyzed as described above. The hydrolysate was derivatized with PITC, and PTC-amino acid separation was performed on an ABI 1 30A separation system, employing a sodium acetate/acetonitrile buffer elution system with a 2.1 X 220-mm C-1 8 column. Amino acid analysis was also performed by the picotag method without vinylpyridine derivatization, consisting of vapor phase hydrolysis (6 N HCl, 24 h, 108°C) on a "workstation," and PTC-amino acid separation on a model 840 HPLC system (Waters Associates, Milford, MA). Derivatization and separation protocols were obtained from the manufacturer (20) . A computer algorithm that yields a best fit total amino acid composition based on a given molecular weight range was used to generate the amino acid compositions.
Results
Localization of CP activity to mast cells from skin. Mast cell CP has been localized to human mast cells from lung, but detected only in crude skin extracts and in partially purified dispersed populations of human mast cells from skin (9) . Dispersed skin cells contain multiple cell types, notably keratinocytes, fibroblasts, and endothelial cells (21) . To confirm the mast cell association of CP activity in skin, the distribution of mast cells and CP activity was examined in discontinuous Percoll gradient fractions of dispersed skin cells (n = 3). The results of one experiment are shown in Table I Purification of human mast cell CP from skin extracts. Since the CP activity in skin extracts is mast cell associated and is similar to the human lung mast cell CP with respect to function, molecular weight, and inhibition profile, human skin served as the source for the purification of this CP. Whole-skin extracts obtained from 50-80 g skin (wet weight) were each subjected to PCI affinity chromatography (Fig. 1) . The CP activity present in each fraction could be 100% inhibited by PCI, and protein in the eluate was undetectable. The results of one preparation of purified CP are shown in Table II . A 1,348-fold purification was achieved with a specific activity of 36.4 U/flg protein. The specific activities of the two other preparations were 29 and 25 U/,ug protein.
The affinity-purified CP was examined for purity by HPLC, spectral analysis, S-200 gel filtration, and SDS-PAGE.
PCI affinity-purified material (5 Mg) was analyzed by HPLC, and a single peak eluted at 36.75 min at 43% acetonitrile (Fig. 2 A) . Spectral analysis (A210-A40o) ofthree areas across the peak exhibited complete spectral superimposition (Fig. 2 B) , a result consistent with a single protein.
Next, PCI affinity-purified protein (840 ug) was subjected Volume (ml) Figure 1 . PCI affinity chromatography of human mast cell CP from whole-skin extracts using a 1 -ml column. 5-ml fractions were collected and assayed for protein and enzyme activity.
to Sephacryl S200 gel filtration. CP activity was detected in fractions corresponding to an apparent molecular mass, of 30,000-35,000 D (not shown). After pooling and concentration of active fractions, 21% and 38% ofthe activity was recovered in each of two preparations.
Affinity-purified material (2 Mg) was also subjected to SDS-PAGE. Reduced material demonstrated a single staining protein band of an apparent molecular mass of 34,500 D (Fig.  3) , consistent with the molecular weight ofthe affinity-purified material as determined by S-200 gel filtration. A faint band, not visible in Fig. 3 , of 57,000 D was seen only in the absence of reducing agent, and was not seen in reduced enzyme preparations even on overloaded gels.
Partial structural characterization. The amino-terminal amino acid sequence of 100 pmol of affinity-purified carboxypeptidase was determined. The first 28 residues of mast cell carboxypeptidase were unambiguously identified and are depicted along with published sequences of human and bovine pancreatic CPA and CPB (22) (23) (24) (Table III) . These sequences were examined for identity with the homologous NH2-termini of other CPs. There is 54% positional identity with bovine CPB, but only 18% with bovine CPA over these 28 residues. In this region the extent of identity between bovine CPA and CPB is 21%. When the aminoterminal residues are compared to the known sequences for human pancreatic CPA and CPB (22) , the extent ofidentity of mast cell carboxypeptidase is 19% with CPA and 65% with CPB. Human pancreatic CPA and CPB share 15% positional identity in this region.
A second PCI-purified preparation was subjected to lysylendopeptidase digestion and HPLC separation, which yielded multiple peptides. The major peak eluted at 31 min and was sequenced, demonstrating a single amino acid sequence homologous with residues 61-78 of bovine CPA (not shown). This peptide had 78% identity with bovine CPB and 55% identity with bovine CPA. Bovine CPA and CPB demonstrate 50% positional identity in this region.
The amino acid composition was determined for 100 pmol of a preparation of affinity-purified human mast cell carboxypeptidase which had been used for NH2-terminal amino acid sequencing (Table IV) . This composition is compared to published amino acid compositions ofbovine pancreatic CPA and CPB, and rat mast cell CP. The overall amino acid composition does not characterize the enzyme as CPA or CPB-like. Since the structural data indicated that the mast cell enzyme is more similar in sequence to CPB than CPA, additional substrates known to be hydrolyzed by CPA or CPB were examined to determine whether the mast cell CP was A-like with respect to the cleavage of these substrates. The activities of the human mast cell enzyme, bovine CPA, and bovine CPB were standardized with respect to hydrolysis ofAl, in terms ofthe amount ofdes-Leu'I Al generated as product (see Methods), and the amount of each enzyme which yielded 0.07 U of Al hydrolyzing activity was utilized in the following experiment. Human mast cell CP and CPA generated only des-Leu'0 AI from Al, and 0.14 and 0.35 U ofeach enzyme did not further hydrolyze des-Leu'0 AI. However, in the case of CPB, 0.035 and 0.07 U of enzyme activity also generated 9 and 16 pmol All per minute. Since des-Leu'0 Al was a possible substrate for CPB because it has a basic COOH-terminal amino acid, histidine, its hydrolysis by each enzyme was examined under identical conditions used for Al. Human mast cell CP and bovine CPA caused no detectable hydrolysis of des-Leu'0 Al. However, CPB generated 82 and 159 pmol All/min, indicating that CPB activity hydrolyzed the carboxyterminal Phe8-His9 bond of des-Leu'" Al. To further characterize human mast cell CP using a substrate with another basic carboxy terminus (arginine) known to be hydrolyzed by CPB, each enzyme was incubated with 50 ,gM bradykinin for 30 min. CPB completely hydrolyzed 25 nmol of bradykinin to a single product, des-Arg9 bradykinin. However, CPA (110 U) and human mast cell carboxypeptidase (330 U) caused no detectable hydrolysis of bradykinin. Since des-Arg9 bradykinin has a COOH-terminal phenylalanine, and is therefore a possible substrate for CPA and mast cell CP, it was evaluated as a possible substrate for these enzymes. CPA (56 U) hydrolyzed 30% of des-Arg9 bradykinin, but mast cell CP (70 and 175 U) caused no detectable hydrolysis of this substrate. Next, the hydrolysis by mast cell carboxypeptidase of two synthetic NH2-substituted dipeptides, N-CBZ-Gly-Phe and N-CBZ-Gly-Arg, substrates ofCPA and CPB, respectively, was examined using 0.5 mM substrate. The hydrolysis of N-CBZ-Gly-Phe was dose dependent, with initial velocities of 0.005-0.31 A224/min using 25-125 U of enzyme. Equivalent amounts of mast cell carboxypeptidase caused no hydrolysis of N-CBZ-Gly-Arg. Thus, human mast cell carboxypeptidase is A-like with respect to its ability to hydrolyze Al and N-CBZGly-Phe, but under the conditions of these experiments is distinguished from CPA by its inability to hydrolyze des-Arg9 bradykinin. Ile-Pro-Gly-Arg-His-Ser-Tyr-Ala-Lys-Tyr- 
Discussion
Human mast cell CP is a mast cell secretory granule enzyme (9) . Human mast cell CP was purified to homogeneity from human skin using a single-step affinity chromatography procedure (Fig. 1) . It has an apparent molecular mass of 30,000-35,000 D by gel filtration (Fig. 2) , and is a single polypeptide chain of 34,500 D by SDS-PAGE (Fig. 3) (6, 9) . It is active at neutral to alkaline pH, and is inhibited by PCI (9) . Studies comparing the kinetic constants of human mast cell CP with bovine pancreatic CPA and CPB, using a series of synthetic di-and tripeptide substrates substituted at the COOH-terminal amino acid, will be required to quantitatively compare the substrate specificities of the three enzymes. However, like CPA, human mast cell carboxypeptidase hydrolyzes Al and N-CBZ-Gly-Phe, and does not hydrolyze des-Leu'0 Al, bradykinin, and N-CBZ-Gly-Arg. It is unlike CPA under the conditions used in these experiments in its inability to hydrolyze des-Arg9 bradykinin. Therefore, these studies indicate that the activity of mast cell CP is similar but not identical to pancreatic CPA. Amino acid sequence data for pancreatic CP show that CPA and CPB arose from a common ancestor by gene duplication (24, 25) . The amino acid sequences of two portions of mast cell CP demonstrate significant positional identity with CPB (Table III) . However, the functional and structural differences between mast cell carboxypeptidase and the wellcharacterized pancreatic CPs demonstrate that the human mast cell enzyme is neither CPA nor CPB, and should be designated mast cell CP. While the data suggest that human mast cell CP may be homologous to the pancreatic CPs, CPA and CPB, further amino acid and nucleotide sequence data will be required to conclusively confirm this, and to elucidate the basis of the substrate specificities of these enzymes (25) . Human mast cell CP is likely to be orthologous to mast cell CPs of other species. A CP activity was first identified in rat mast cells (6, 8) , was thought to be CPA-like, and was recently identified in mouse mast cells (7) . Functionally CPA-like CP has been purified from rat peritoneal mast cells (6) , and from rat skeletal muscle mast cells (8) . While the amino acid sequences of the rodent mast cell CPs are not known, these enzymes have a similar molecular mass, pH optimum, inhibitor profile, and amino acid composition to the human mast cell enzyme. The purified rat peritoneal mast cell CP was CPB-like with respect to half-cystine and methionine content, and differed from CPA with regard to Km and Keat values for N-CBZ-Gly-Phe (6). The purified rat skeletal muscle CP differed from bovine pancreatic CPA in thermal lability and stability of the purified holo and apoenzyme (8) .
Quantitative studies using a functional standard demonstrate that the content of CP in adult foreskin mast cells (16 '4g/ 106 cells) falls between those of tryptase (35 Ug/106 cells) and chymase (4.5 ,ug/106 cells) (26) . Human mast cell CP activity is higher in mast cells from human skin vs. lung (9) , and in adult vs. neonatal skin. This distribution of CP is similar to that of chymase, a marker for a subset of tryptase-positive, chymase-positive mast cells (TC type) abundant in human skin (26, 27) . TC type mast cells are relatively uncommon in human lung, which contains primarily tryptase-positive, chymase-negative (T type) mast cells (27) . Therefore, one may speculate that CP, like chymase, may also be a biochemical marker for the TC type of mast cell abundant in human skin.
Recent observations (7) suggest that mast cell CP may be a differentiation marker in the mouse. The biologic role for CP and other mast cell enzymes is unclear. It is possible that these enzymes confer a unique biochemical potential to mast cells in skin which may be reflected in disorders mediated by mast cells in skin in which tissue destruction is a significant aspect (28) .
